Douglas Jabs
Physician · Johns Hopkins School of Medicine
Credentials: · · · ·
History
- 2019–Present
1978–1981- 1977–1978
Preliminary Internal Medicine
- 1973–1977
Research
Review · American Journal of Ophthalmology · 2005 · First of 4 authors · Corresponding · 3,668 citations
Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia
Case report · New England Journal of Medicine · 1990 · 815 citations
Review · American Journal of Ophthalmology · 2000 · First of 12 authors · Corresponding · 728 citations
128 papers · 4 as a resident
- JK
96 papers
62 papers · 9 as a fellow
61 papers
50 papers · 7 as a resident
- GL
49 papers
- ES
47 papers
- RN
47 papers
Grants
- 2026–2031
Researching OCT Biomarkers in UveitiS Clinical Trials (ROBUST)
National Eye Institute · R01
PI · $722.9K · University of California Los Angeles
- 2016–2026
Immunologic Determinants of Age-Related Macular Degeneration (AMD)
National Eye Institute · R01
Contact PI · $3.4M · Johns Hopkins University
- 2018–2025
Adalimumab Versus Conventional Immunosuppression for Uveitis (Advise) Trial
National Eye Institute · UG1
Contact PI · $1.2M · Johns Hopkins University
- 2014–2022
Macular Edema Treatment Trials Associated with Must (Meta-Must)
National Eye Institute · U10
Contact PI · $1.9M · Johns Hopkins University
Clinical trials
- 2019–2024
Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
Study chair · Completed · Phase 3
JHSPH Center for Clinical Trials
- 2017–2022
Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
Study chair · Completed · Phase 3
JHSPH Center for Clinical Trials
- 2015–2018
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Study chair · Completed · Phase 3
JHSPH Center for Clinical Trials
- 2005–2010
Multicenter Uveitis Steroid Treatment (MUST) Trial
Study chair · Completed · Phase 4
JHSPH Center for Clinical Trials